In today’s market, investors are scanning for deeply undervalued stocks with disruptive technology, breakthrough clinical assets, and high-impact news catalysts. Several oversold equities trading under $1 have emerged with notable developments, drawing algorithmic attention across trading platforms, financial news networks, and Google-indexed search results.
N2OFF Inc. (NASDAQ: NITO), previously known as Save Foods, is building traction with its eco-friendly crop protection solutions. Focused on reducing pesticides, extending shelf life, and improving food safety, N2OFF is aligned with sustainability goals and climate-resilient agriculture trends across global food supply chains.
Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) continues to impress in the mining sector with breakout drill results from its Lion Zone, including 13.54 g/t gold, 236.6 g/t silver, and 1.08% copper over 1.95m (12.64% CuEq). These polymetallic intercepts underscore the company's momentum in battery metals and critical mineral exploration, at a time when the global clean energy transition is driving strong investor interest in undervalued resource stocks.
SciSparc Ltd. (NASDAQ: SPRC) and Clearmind Medicine (NASDAQ: CMND) have co-filed an international patent for a novel psychedelic-based therapy combining 3-MMC and SciSparc’s proprietary PEA formulation. Targeting anorexia, bulimia, and other eating disorders affecting 70+ million people worldwide, this collaboration puts SPRC and CMND on the map for biotech investors tracking mental health innovation.
Peraso Inc. (NASDAQ: PRSO) leads this group, launching its cutting-edge PRM2141X-D mmWave module engineered for high-speed mobile applications across wearables, vehicles, and drones. Peraso also announced an extension of its Series C Warrants from May 6 to August 4, 2025. Priced at $1.61 for up to 2.25 million shares, this strategic move enhances capital flexibility for investors tracking next-gen 60GHz wireless connectivity—placing PRSO in the spotlight of under-$1 tech stocks with significant innovation upside, See more.
Health In Tech (NASDAQ: HIT) is gaining attention after appointing former U.S. Ambassador Edward T. McMullen Jr. to its Advisory Board, enhancing the insurtech firm’s strategic policy outlook. With AI-driven health plans and a growing network of employer clients, HIT is positioned to redefine digital healthcare access—making it one of the top insurtech plays under $1.
NuCana PLC (NASDAQ: NCNA) rounds out the list with its ProTide platform, which is designed to overcome resistance in chemotherapy treatments. The biotech firm’s focus on next-gen oncology solutions continues to position it as a key player in the precision medicine space.
These oversold stocks under $1—PRSO, PNPNF, HIT, SPRC, CMND, NITO, and NCNA—each offer unique catalysts across technology, mining, agriculture, biotech, and healthcare. Whether it’s next-gen wireless, battery metals, psychedelic-based mental health therapies, or AI-powered insurance, these tickers are trending now on Google, StockTwits, and social platforms—making them must-watch plays for investors chasing value and growth in a volatile 2025 market.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
